NEI Translational Research Program on Therapy for Visual Disorders (R24)

Post Date

September 15th 2010

Application Due Date

January 25th 2013

Funding Opportunity Number

PAR-10-281

CFDA Number(s)

93.867

Funding Instrument Type(s)

Grant

Funding Activity Categories

Health

Eligibility Categories

Public and State Controlled Institutions of Higher Education
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education
Other

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs) .

Funding

• Estimated Total Funding:

  $1500000

• Award Range:

  $None - $None

Grant Description

Purpose. The National Eye Institute (NEI) supports multidisciplinary research focusing on the development of novel therapies to treat visual diseases and disorders. The rapid and efficient translation of innovative laboratory research findings into clinical development frequently requires a comprehensive and highly integrated approach involving collaborative teams of scientists and clinicians with expertise in multiple disciplines. Such a collaborative approach is particularly appropriate for research focused on pathways that will likely be targeted by biological intervention, such as gene therapy, cell-based therapy, pharmacological approaches. The intention of this program is to make resources available to scientists from several disciplines to form research teams to address scientific and technical questions that would be beyond the capabilities of any one research group. Each project should have a well-defined end-point, achievable within a five-year time frame, of developing a specific treatment for a specific disease. The steps toward this end-point should be clearly delineated in a series of milestones that support the development of a therapeutic approach, which can then be tested in a clinical trial. Mechanism of Support. This FOA will utilize the National Institutes of Health (NIH) R24 Research Resources Grant award mechanism. Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the numbers, quality, duration, and costs of the applications received.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  National Institutes of Health

• Agency Contact:

  NIH OER Webmaster
  FBOWebmaster@OD.NIH.GOV
  

• Agency Mailing Address:

  If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

• Agency Email Address:

  FBOWebmaster@OD.NIH.GOV

• More Information:

  http://grants.nih.gov/grants/guide/pa-files/PAR-10-281.html